Ensysce Biosciences, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Ensysce Biosciences is registering for the potential issuance and resale of up to 7,455,627 shares of common stock underlying warrants held by selling securityholders.
NASDAQ
Ensysce Biosciences is seeking to raise capital through a public offering of common stock, pre-funded warrants, and common stock purchase warrants.